Loading organizations...
§ Private Profile · London, England, United Kingdom
Medical device company developing wearable diagnostic devices with acoustic sensors for at-home sleep apnea and respiratory monitoring.
Based in London, England, Acurable is a medical device company that develops wearable acoustic sensors for the at-home diagnosis and management of respiratory and cardiovascular conditions. The company's flagship product, AcuPebble, is an FDA-cleared and CE-marked neck-worn sensor that continuously detects obstructive sleep apnea and is supported by a corporate workforce of 21 to 50 employees. Acurable has raised €11 million in Series A funding backed by venture capital firms including Kibo Ventures, Mundi Ventures, and Kindred Capital. The proprietary diagnostic technology is utilized by healthcare providers across multiple European markets, with official recommendations from the National Institute for Health and Care Excellence and adoption by several regional UK NHS trusts. The medical technology enterprise was founded in 2016 as a spin-out from Imperial College London by Professor Esther Rodriguez-Villegas and Emilio Sanz-Pereiras.
Acurable has raised $10.8M across 1 funding round.
Acurable has raised $10.8M in total across 1 funding round.
Acurable has raised $10.8M in total across 1 funding round.
Acurable's investors include Sonia Fernandez, Kindred Capital, Mundi Ventures.
Acurable has raised $10.8M across 1 funding round. Most recently, it raised $10.8M Series A in October 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 3, 2022 | $10.8M Series A | Sonia Fernandez | Kindred Capital, Mundi Ventures | Announced |